Venture capital financing for UK life sciences start-ups soars

Total venture capital funding attracted by the UK life sciences industry rose by 41% last year, to $713m, with two companies developing therapies to boost human beings’ immune response to diseases accounting for the three biggest financing rounds.

WSJ Logo
Aviva Takeover of Direct Line Gets Green Light From U.K. Antitrust WatchdogExternal link

Aviva Takeover of Direct Line Gets Green Light From U.K. Antitrust Watchdog